Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatment

Novartis to acquire Anthos Therapeutics for USD 925 million upfront, bolsters late-stage cardiovascular pipeline

Written By Ruchika Sharma11 Feb 2025 5:50 PM IST

Basel: Novartis today announced that it has entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, privately held,...

Sanofi secures approval in India for chronic graft-versus-host disease drug Rezurock

Written By Ruchika Sharma11 Feb 2025 4:30 PM IST

Sanofi Healthcare India Pvt. Limited has announced receipt of marketing authorization for Rezurock (Belumosudil Tablets) in India....

Eye condition NAION is a very rare side effect of semaglutide: EMA safety committee

EMA establishes regular procedure for scientific advice on certain high-risk medical devices

Written By Ruchika Sharma11 Feb 2025 3:30 PM IST

European Medicines Agency (EMA), in close collaboration with the European Commission, has established a standard procedure for manufacturers of...

Bayer Finerenone approved in Japan for chronic heart failure

Bayer files for approval of extended 6 month treatment interval for Eylea 8 mg in EU

Written By Ruchika Sharma11 Feb 2025 11:30 AM IST

Berlin: Bayer has submitted an application to the European Medicines Agency (EMA) to expand treatment intervals of up to 6 months with Eylea...

Lupin Launches Bioequivalent of Xigduo XR in US Across Multiple Strengths

Lupin bags USFDA nod for Ipratropium Bromide Nasal Solution for rhinorrhea

Written By Ruchika Sharma11 Feb 2025 10:30 AM IST

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (USFDA) for...

Abhayrab Safe via Authorised Channels, Clarifies Indian Immunologicals Amid Fake Vaccine Alerts

Bharat Biotech group company Biovet gets CDSCO license for Lumpy Skin Disease vaccine

Written By Ruchika Sharma10 Feb 2025 5:47 PM IST

Bengaluru: Bharat Biotech group company Biovet, an innovative animal health vaccine producer based in Mallur, Karnataka, has announced that its...

CDSCO Delegates Veterinary Drug Licensing Powers to Zonal Offices to Ease Approvals

Telangana DCA seizes Alka-Shot Oral Solution in Bhupalpally

Written By Ruchika Sharma10 Feb 2025 2:30 PM IST

Telangana: Drugs Control Administration, Telangana has seized 'Alka-Shot Oral Solution," an Allopathic medicine, in Bhupalpally for making...

Natco Pharma gets final approval for Bosentan tablets for oral suspension

Written By Ruchika Sharma10 Feb 2025 11:30 AM IST

Hyderabad: NATCO Pharma Limited has announced final approval of its Abbreviated New Drug Application (ANDA) for Bosentan tablets for oral...

USFDA Closes Inspection of Dr Reddys Srikakulam Facility with VAI Classification

Dr Reddy's Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe

Written By Ruchika Sharma7 Feb 2025 1:30 PM IST

Hyderabad: Dr Reddy's Laboratories SA, a wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd. has announced that it has entered into a ...

Sun Pharma, Philogen complete patient enrollment in Phase III trial for Soft Tissue Sarcoma

Written By Ruchika Sharma7 Feb 2025 12:30 PM IST

Mumbai: Sun Pharmaceutical Industries Limited and Philogen S.p.A. have announced the successful completion of patient enrollment in the Phase III...

Biocon unveils Liraglutide for diabetes, obesity in Netherlands

Biocon, Equillium announce positive data from Phase 2 Study evaluating Itolizumab for Ulcerative Colitis

Written By Ruchika Sharma7 Feb 2025 11:30 AM IST

Bengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global biopharmaceutical company, have...

Caplin Steriles Secures USFDA Nod for Generic DEPO-MEDROL Injection

Caplin Steriles gets USFDA nod for Procainamide Hydrochloride Injection for treating abnormal heart rhythm

Written By Ruchika Sharma6 Feb 2025 1:30 PM IST

Chennai: Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval by the United...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok